Reports Q3 revenue $1.35B, consensus $1.33B. “We are very pleased with our Q3 performance as strong discharge growth facilitated an increase of 11.9% in revenue and 13.4% in Adjusted EBITDA,” said President and CEO, Mark Tarr. “Our teams did an exemplary job managing through very challenging conditions posed by Hurricanes Helene and Milton, prioritizing patient safety and continuity of operations. We thank our employees for their resilience and dedication to providing the highest quality care for our patients.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EHC:
